StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.17−0.95 (-4.97%)

Close on Nov 17, 2026Market cap $972.65MP/E –Yield –

Seaport Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Seaport Therapeutics's price to book ratio was 2.7× on Nov 11, 2026.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.7×–

More Seaport Therapeutics figures

See a number that looks wrong?